BlueStone Jewellery IPO GMP at 2%; subscription warms up

Right when investors thought the IPO market was cooling, BlueStone Jewellery’s debut has sparked fresh chatter. The IPO has kicked off at a gentle 2 per cent grey-market premium (GMP), signalling cautious optimism rather than frenzied bidding.

Let’s unwrap what’s really happening on the subscription counters, and what it means for you.

What’s happening with the BlueStone Jewellery IPO?

The IPO opened today (August 11, 2025) and runs until Wednesday (August 13, 2025). It comprises a fresh issue of Rs 820 crore and an offer for sale of about Rs 720.6 crore, targeting a combined funding of around Rs 1,541 crore.

The GMP is hovering around Rs 9, translating to roughly a 1.74 per cent premium over the upper price band of Rs 517. While GMP isn’t a regulated metric, it serves as a quick barometer of sentiment among grey-market traders.

BlueStone Jewellery IPO latest subscription status

As of the latest available data:

• Overall: 0.02x
• QIB: 0.00×
• NII: 0.01× 
• Retail (RII): 0.09x

The numbers suggest volumes are still warming up as this IPO hasn’t yet seen the kind of rush that pushes early subscription figures sky-high.

Why investors are watching

With its design-driven, omni-channel brand and strong back-office tech, BlueStone is more than just another jewellery retailer, it’s a modern growth story with notable revenue traction. However, widening net losses and a heavy inventory cycle mean investors are still weighing the risks.

Our view

BlueStone’s IPO is off to a patient start—steady but unspectacular. The modest GMP is encouraging, but the slow subscription trend shows caution still dominates. For investors, this could be a case of “watch closely, move decisively.”

Should you apply to the BlueStone Jewellery IPO?

If you’re tempted by the sparkle of listing gains, remember that IPO investing rewards preparation over impulse. Check where BlueStone stands on Value Research Stock Advisor’s Quality, Growth, Valuation and Momentum scores. A quick peek could help you decide whether to stay patient or act before the crowd moves.

Explore Stock Advisor today

Disclaimer: This article was crafted with the aid of artificial intelligence and meticulously reviewed and edited by our human experts to ensure accuracy and provide valuable insights. It's intended for informational purposes only. We encourage you to conduct your own thorough research before making any investment decisions.